Lexicon Pharmaceuticals
LXRX
#6776
Rank
C$1.11 B
Marketcap
C$2.51
Share price
1.16%
Change (1 day)
15.98%
Change (1 year)

Lexicon Pharmaceuticals (LXRX) - Total debt

Total debt on the balance sheet as of June 2026 : C$84.43 Million

According to Lexicon Pharmaceuticals 's latest financial reports the company's total debt is C$84.43 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Lexicon Pharmaceuticals - Total debt on balance sheet (from 2000 to 2026)

Total debt by year

Year Total debt Change
2025-12-31C$86.02 M-44.69%
2024-12-31C$0.15 B10.57%
2023-12-31C$0.14 B87.49%
2022-12-31C$75.03 M2483.32%
2021-12-31C$2.9 M-82.22%
2020-12-31C$16.33 M-94.91%
2019-12-31C$0.32 B-3.83%
2018-12-31C$0.33 B8.05%
2017-12-31C$0.30 B126.56%
2016-12-31C$0.13 B-4.53%
2015-12-31C$0.14 B14.28%
2014-12-31C$0.12 B436.52%
2013-12-31C$23.28 M-0.14%
2012-12-31C$23.31 M-7.91%
2011-12-31C$25.32 M-11.06%
2010-12-31C$28.47 M-59.59%
2009-12-31C$70.45 M90.04%
2008-12-31C$37.07 M18.46%
2007-12-31C$31.29 M-16.49%
2006-12-31C$37.47 M-12.86%
2005-12-31C$43 M-4.85%
2004-12-31C$45.19 M-38.16%
2003-12-31C$73.08 M1056.92%
2002-12-31C$6.31 M
2000-12-31C$4.26 M-38.13%
1999-12-31C$6.89 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Thermo Fisher Scientific
TMO
C$60.60 B 71,677.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
C$3.62 B 4,191.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
C$3.85 B 4,465.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
C$51.27 M-39.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
C$1.61 B 1,808.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
C$0.35 B 326.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
C$0.47 B 468.47%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$5.98 B 6,988.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
C$0.49 M-99.41%๐Ÿ‡บ๐Ÿ‡ธ USA